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The objective of this study was to evaluate the ability of
lasers and microdermabrasion, both of which are skin
resurfacing modalities, to enhance and control the in vitro
skin permeation and deposition of vitamin C.The topi-
cal delivery of magnesium ascorbyl phosphate, the pro-
drug of vitamin C, was also examined in this study. All
resurfacing techniques evaluated produced signi¢cant
increases in the topical delivery of vitamin C across
and/or into the skin. The erbium:yttrium-aluminum-
garnet (Er:YAG) laser showed the greatest enhancement
of skin permeation of vitamin C among the modalities
tested. The laser £uence and spot size were found to
play important parts in controlling drug absorption.
An excellent correlation was observed in the Er:YAG la-
ser £uence and transepidermal water loss, which is an
estimation of skin disruption. Permeation of magne-
sium ascorbyl phosphate was not enhanced by the
Er:YAG laser. The CO2 laser at a lower £uence pro-
moted vitamin C permeation with no ablation of the
stratum corneum or epidermal layers. Further enhance-
ment was observed with the CO2 laser at higher £u-
ences, which was accompanied by a prominent
ablation e¡ect. Microdermabrasion ablated the stratum
corneum layers with minimal disruption of the skin
barrier properties according to transepidermal water
loss levels. The £ux and skin deposition of vitamin C
across microdermabrasion-treated skin was approxi-
mately 20-fold higher than that across intact skin. The
techniques used in this study may be useful for basic
and clinical investigations of enhancement of topical vi-
tamin C delivery. Key words: lasers/skin/topical applica-
tion/vitamin C. J Invest Dermatol 121:1118 ^1125, 2003
V
itamin C (L-ascorbic acid) has important physiolo-
gic e¡ects on skin, including inhibition of mela-
nogenesis, promotion of collagen biosynthesis,
prevention of free radical formation, and accelera-
tion of wound healing (Darr et al, 1992; Austria
et al, 1997; Boyce et al, 2002). The stratum corneum (SC) provides
the principal barrier that limits the percutaneous amount and rate
of topical vitamin C application (Lee and Tojo, 1998; Zhang et al,
1999). Lasers are physical devices that have been used for medical
diagnoses and therapeutic purposes, and have been suggested for
the controlled ablation or removal of the SC (Lee et al, 2002). The
duration of laser procedures on the skin is in the range of nano-
seconds to microseconds, indicating that enhancement of drug
permeation across laser-pretreated skin occurs in a very short
time.
Many types of lasers have been developed and are used in der-
matology. The erbium:yttrium-aluminum-garnet (Er:YAG) laser
can ablate the SC layer with minimal residual thermal damage
to the skin; it is currently used for the resurfacing of rhytides,
scars, and photodamage (Manaloto and Alster, 1999). The CO2
laser also has the ability to resurface skin. The procedure for SC
ablation by the CO2 laser is accompanied by heating (Marcells
and Ellis, 2000). The CO2 laser may be bene¢cial in enhancing
topical drug delivery because the thermal e¡ect can induce skin
permeability to a drug. In addition to lasers, microdermabrasion
is a process that uses Al2O3 crystals and negative pressure to peel
o¡ super¢cially the outer surface of the skin (Lloyd, 2001).
Microdermabrasion has the advantages of less bleeding, fewer
complications, and no need for local anesthesia in comparison
with other super¢cial peeling techniques (Tsai et al, 1995).
The aim of this study was to evaluate the feasibility of lasers
and microdermabrasion in controlling and enhancing the topical
delivery of vitamin C, a model hydrophilic molecule, using an
in vitromodel of nude mouse skin. Although the nude mouse skin
is more permeable than human skin (Catz and Friend, 1990; Fang
et al, 1999), it is still a good model for examining the skin permea-
tion of drugs because of the limited variability among individuals
and similar hair follicle density to human skin. The use of vita-
min C is limited due to its low stability in products. Magnesium
ascorbyl phosphate (MAP), a new derivative of vitamin C with a
hydrophilic characteristic, is more stable than vitamin C in for-
mulations (Semenzato et al, 1995). Hence MAP was also used for
permeation into and/or across the skin after SC peeling as a
comparison with vitamin C. Histologic examination by light mi-
croscopy and transepidermal water loss (TEWL) determination
were also used to elucidate changes in the skin structure and the
mechanism of drug permeation across laser- and microdermabra-
sion-treated skin. All resurfacing techniques tested in this study
used lower energies or shorter treatment durations than those
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utilized in clinical situations. The combination of chemical vita-
min C and physical lasers or microdermabrasion may be also ap-
plicable in the ¢eld of medical cosmetology for rejuvenation.
The animal experiment protocol was reviewed and approved
by the Institutional Animal Care and Use Committee of Chang
Gung University. The committee deemed the animal experiment
follows the guidelines as shown in the Guide for Laboratory
Factlines and Care.
MATERIALS AND METHODS
Laser and microdermabrasion assemblies The Er:YAG laser, CO2
laser, and microdermabrasion were used to pretreat nude mouse skin from
the region of the back (BALB/C-nu strain, 6^8 wk old). The Er:YAG
laser (Continuum Biomedical, Dublin, California) had a wavelength of
2940 nm and a pulse duration of 250 ms. An articulated arm was used to
deliver the laser beam on to the skin. Output energies of 0.35, 0.45, and
0.55 J per pulse and beam spot diameters of 5 and 7 mm achieved £uences
of 0.9 to 2.8 J per cm2.
The experimental skin was also treated with one pass of a CO2 laser
(Surgipulse 150XJ, ESC Sharplan, Yokneam, Israel) with a pulse duration
of 50 ms in the surgipulse or superpulse mode, depending on individual
£uences. This laser delivered £uences of 1.4, 4.0, and 7.0 J per cm2. The
beam diameter of the CO2 laser was 3 mm.
The microabrasor (Pepita-C, Mattioli Engineering, Florence, Italy) has a
system of aspiration-compression within a £exible tube, which is
connected to the machine and the hand-piece. Al2O3 crystals are ¢red
from the compression system via a nozzle at a vacuum pressure of 3 bar
with the hand-piece in contact with the skin for 2, 3, or 4 s. The used
microcrystals are reabsorbed through an aspiration system and shunted to
a waste container.
Histologic examination of skin Histologic changes in nude mouse
skin were examined after laser irradiation and microdermabrasion.
Immediately after treatment, a specimen of exposed area was taken from a
live nude mouse for histologic examination. The adjacent untreated skin
area was also assessed as the control group. Each specimen was ¢xed in
10% bu¡ered formaldehyde solution at pH 7.4 for at least 48 h. The
specimen was cut vertically against the skin surface. Each section was
dehydrated using ethanol, embedded in para⁄n wax, and stained with
hematoxylin and eosin. For each skin sample, three di¡erent sites were
examined and evaluated under light microscopy (Nikon Eclipse 4000,
Tokyo, Japan). Photomicrographs of the three randomly selected sites of
each skin sample were taken with a digital camera (Coolpix 950, Nikon).
The digital photomicrographs were then processed with Adobe
PhotoDeluxe (Adobe Systems, California), and the SC and epidermal
thicknesses were calculated with ImagePro-plus 4.0 (Media Cybernetics,
Silver Spring, Maryland). The ¢nal thicknesses were the averages from at
least three animals.
Test formulations A 50% glycerin aqueous solution was selected as the
test formulation in donors based on stability studies of vitamin C in
various solutions (Lee and Tojo, 1998). The experimental results also
showed that glycerin in the donor solution did not change the skin
permeation properties. Hence 85 mM of vitamin C or MAP in 50%
glycerin/pH 3.5 citrate phosphate bu¡er was used as the donor vehicle. All
drug-containing formulations were freshly prepared prior to the
experiments.
In vitro topical application of vitamin C and MAP The di¡usion cell
used in this in vitro study was a Franz vertical di¡usion assembly. Female
nude mice (6^8 wk old) were euthanized by ether and full-thickness skin
was excised from the dorsal region. A piece of excised skin was mounted
on the receptor compartment with the SC side facing upwards into the
donor compartment. To obtain SC-stripped skin, adhesive tape (Four
Pillars Co., Sanchung, Taiwan) was applied to nude mouse skin with
uniform pressure and then removed. This procedure was repeated 20
times. Each stripped skin was examined by light microscopy to avoid the
possible discrepancy among the morphology and thickness of these
stripped skins. The laser hand-piece was located approximately 3.7 cm
from the surface of the skin. After pretreatment with a laser or
microdermabrasion, the skin surface was wiped with a cotton wool swab
several times. The receptor compartment (10 mL) was ¢lled with a
glycerin/pH 7.4 citrate phosphate bu¡er (1:1) mixture. The donor
compartment was ¢lled with 1 mL of the test formulation. The available
area of the Franz cell was 1.54 cm2. The receptor compartment was
maintained at 371C and stirred by a magnetic bar at 600 r.p.m. At
appropriate intervals, 200 mL aliquots of receptor medium were
withdrawn and immediately replaced by an equal volume of fresh
receptor solution. The samples were analyzed by high-performance liquid
chromatography (HPLC) methods. Each experiment included four
replicates. The in vitro permeation experiments demonstrated that within
the limit of detection of 2 ng per mL of the HPLC assay, no measurable
amount of MAP was obtained in the receptor during 12 h. It may suggest
that MAP was almost converted to vitamin C in the nude mouse skin.
Hence the vitamin C amount (converted from MAP) was used to
calculate the £ux and skin deposition of MAP.
The amount of vitamin C retained in the skin was determined at the
end of the in vitro experiment (12 h). The application site on the skin was
washed 10 times using a cotton cloth immersed in distilled water. A sample
of skin was weighed, cut with scissors, positioned in a glass homogenizer
containing 1 mL of methanol, and ground for 5 min with an electric
stirrer. The resulting solution was centrifuged for 10 min at 9,279 g r.p.m.
The supernatant was analyzed by HPLC. The weight of each skin piece
was used to calibrate the drug amount in skin for the ¢nal unit of mg per mg.
HPLC analytical methods The vitamin C content of the various
samples was analyzed with a HPLC system consisting of a Hitachi L-7110
pump, a Hitachi L-7200 sample processor, and a Hitachi L-7400 ultraviolet
detector. A 25 cm long, 4 mm inner diameter stainless steel RP-18-NH2
column (Merck, Darmstadt, Germany) was used. The mobile phase,
consisting of 70:30 methanol/pH 3.5 citrate phosphate bu¡er was used at a
£ow rate of 1 mL per min. The mobile phase for MAP was 40:60
acetonitrile/pH 3.5 citrate-phosphate bu¡er at a £ow rate of 1 mL per min.
The ultraviolet detector was set at a wavelength of 255 nm for both
vitamin C and MAP (Semenzato et al, 1995).
TEWL determination The dorsal skin of a live nude mouse was treated
with a laser or microdermabrasion. After 30 min,TEWLwas quantitatively
measured using an evaporimeter (Tewameter 300, Courage and Khazaka,
Cologne, Germany). The TEWL value was automatically calculated and
was expressed in g per m2 per h. An adjacent untreated site was used as a
baseline standard for each determination.The measuring area of theTEWL
probe was 0.785 cm2. Each experiment included four replicates.
Data analysis In the in vitro permeation study, the total amount of drug
permeating across a unit di¡usion surface and into the receptor was
calculated and plotted as a function of time. The £ux was calculated by
the slope of the linear portion of the cumulative amount^time plots for a
zero-order model and are expressed as the mass of drug passing across 1
cm2 of skin over time. This study shows that limited ablation-pretreated
areas of di¡usion of the skin were 12.75% and 24.99% for 5 mm and 7
mm diameter hand-pieces of the Er:YAG laser, respectively, for one pulse,
18.36% for the 3 mm diameter hand-piece of the CO2 laser for four pulses
at di¡erent sites, and 48.96% for the 0.754 cm2 oval-shaped hand-piece of
the microdermabrasion unit of the total permeated skin surface area. The
data of cumulative amount, £ux, drug reservoir within the skin, and
TEWL of the treated area were extrapolated to an area of 100% ablation
of the permeated area by the following equation:
Q100% ¼ Qtreat  Qcontrol A100%  Atreat=A100%
 
100%
  
A100%=Atreat
where Q100% represents the permeation data (cumulative amount, £ux,
drug reservoir within the skin, and TEWL) across 100% treated skin
(calibrated data), Qtreat represents the data across partially treated skin in
the Franz cell or in skin surface (original data), Qcontrol represents the data
across nontreated skin, A100% is the area (cm
2) of the total di¡usion area,
and Atreat is the area of the laser-treated site or microdermabrasion-treated
site. The ratio of the permeation data across 100% treated skin to the value
across nontreated skin (control group) was calculated as the enhancement
ratio (ER).
The statistical analysis of di¡erences between di¡erent treatments was
performed using the unpaired Student’s t test. A 0.05 level of probability
was taken as the level of signi¢cance. The ANOVA test was also utilized in
this study.
RESULTS
Histologic examination of skin Nude mouse skin was
exposed to lasers and microdermabrasion using various energies
to determine their e¡ects on the integrity of the skin structure.
Light microscopy indicated no observable damage to whole skin
LASERS AND MICRODERMABRASION 1119VOL. 121, NO. 5 NOVEMBER 2003
in the nontreated group (Fig 1a). The tape-stripped skin showed
that almost no SC existed in the stripped skin (Fig 1b). Moreover,
the thickness of the epidermis was not changed after the strip
(Table I). Histologic observations demonstrated that Er:YAG
laser ablation achieved partial removal of the SC as shown in
Fig 1(c). Higher £uences of the Er:YAG laser generally induced
deeper SC/epidermal ablation after calculating the thickness by
microscopy (Table I). The histologic photographs also showed
there to be no signi¢cant changes in structural features of the
epidermis or dermis with treatments at 0.9 and 1.2 J per cm2.
As compared with the Er:YAG laser at the same irradiated
energies (1.4 J per cm2), the CO2 laser induced little tissue
ablation or histologic changes to the skin (Table I). The higher
energies (4.0 and 7.0 J per cm2) of the CO2 laser indeed
produced signi¢cant SC/epidermal ablation; however, thermal
necrosis in the epidermis and upper dermis was observed in
treated skin as shown in Fig 1(d). Vessel congestion was also
shown in the dermis. The higher £uences led to more signi¢cant
ablation of the SC thickness for the CO2 laser. There was a linear
relationship between the etched depth of the SC and the £uences
Figure1. Histologic examination of nude mouse back skin by nontreatment (control group) (a); the tape-stripped group (b); Er:YAG laser at
1.2 J per cm2 (c); CO2 laser at 4.0 J per cm
2 (d). microdermabrasion for 3 s (e). Original magni¢cation  200.
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tested (correlation coe⁄cient, r¼ 0.9941), suggesting that SC
removal can be precisely controlled by the CO2 laser. Light
microscopy showed thinning of the SC with focal compaction
after treatment. Retention of Al2O3 crystals was observed on
the surface of the SC (Fig 1e). No change in the viable
epidermis/dermis of treated skin was noted when compared
with the control. The e¡ect of ablation by microdermabrasion
was approximately that of levels of the Er:YAG laser at 0.9 and
1.2 J per cm2 (Table I). Moreover, the depth of SC ablation was
comparable (p40.05) with microdermabrasion treatment for 2, 3,
and 4 s.
Topical delivery of vitamin C by Er:YAG laser The
cumulative amount of vitamin C (mg per cm2) in the receptor as
a function of time is shown in Fig 2. As shown inTable II, the
£ux of vitamin C dramatically increased by 350.92-fold after
stripping the SC of the skin, suggesting the major barrier
presented by the SC to the permeation of vitamin C. Skin
deposition of vitamin C also greatly increased with SC
stripping, but the ratio of the enhancement was lower than for
the data on £ux (Table III). Results in Fig 2(a) demonstrate
that the Er:YAG laser was e¡ective in enhancing skin
permeation of vitamin C for all intensities tested. Extrapolating
the £ux data of the laser-irradiated area to an area of 100%
exposure resulted in an ERvalue of about 100 for £uences of 0.9
and 1.2 J per cm2 (Table II). The comparable changes in skin
structure by £uences of 0.9 and 1.2 J per cm2 may have resulted in
similar enhancement of vitamin C permeation. The more
signi¢cant changes in skin structure with the 1.4 J per cm2
intensity led to a higher enhancement ratio (142.05) of vitamin
C £ux. In addition to evaluating the e¡ect of a single pulse, the
e¡ect of multiple pulses at the same treated site was determined.
The results inTable II show that the enhancement of vitamin C
permeation by two pulses at 0.9 J per cm2 was comparable with
that of a single pulse (p40.05).
The e¡ect of laser spot size on the permeation of vitamin C
was additionally investigated as listed inTable II. A smaller spot
size resulted in greater £uence on the skin based on the same
output energy (J). The 5 mm probe produced higher vitamin C
£ux than did the 7 mm probe at the same outputs (0.35 and 0.55
J). This enhancement was not observed in the skin deposition of
vitamin C, however (Table III).
Topical delivery of MAP by the Er:YAG laser The in vitro
topical delivery of MAP across Er:YAG laser-treated skin was
studied to compare the permeation data of vitamin C.
Preliminary permeation experiments demonstrated that within
the limit of detection of 2 ng per mL of the HPLC assay, no
measurable amount of MAP was obtained in the receptor
during 12 h. The £ux of MAP across intact skin was comparable
with that of vitamin C as shown in Table IV (p40.05). Tape-
stripping only increased the MAP £ux by 12.39-fold, which was
Table I. SC and epidermal thickness of nude mouse skin after ablation of Er:YAG laser, CO2 laser, or microdermabrasion
Ablation type
Fluence
(J per cm2 or seconds)
SC thickness
(mm)
Viable epidermal
thickness (mm)
Nontreatment 0 11.672.2 18.578.3
SC-stripped 0 1.273.2a 16.875.9
Er:YAG 0.9 (7 mm, 0.35 J) 6.671.7a 17.171.2
Er:YAG 1.2 (7 mm, 0.45 J) 5.971.2a 16.872.8
Er:YAG 1.4 (7 mm, 0.55 J) 1.372.3a 5.172.0a
CO2 1.4 (3 mm, surgipulse) 13.971.1 23.376.4
CO2 4.0 (3 mm, surgipulse) 7.272.7
a 6.271.8a
CO2 7.0 (3 mm, powerpulse) 1.971.7
a 3.070.8a
Microdermabrasion 2 s (4 6 mm, 3 bar) 6.870.9a 18.172.3
Microdermabrasion 3 s (4 6 mm, 3 bar) 4.972.3a 18.170.9
Microdermabrasion 4 s (4 6 mm, 3 bar) 4.870.8a 18.972.7
app0.05 as compared with the SC and epidermal thickness of non-treatment group.
Each value represents mean7SD (n¼ 3).
Table II. The £uxes and enhancement ratios of vitamin C across nude mouse skin by treatment of lasers and microdermabrasion
Laser type
Fluence
(J per cm2 or seconds)
Original £ux
(mg per cm2 per h)a
Normalized £ux
(mg per cm2 per h)b
Enhancement ratio
(ER£ux)
c
Nontreatment 0 1.1970.24 ^ ^
SC stripping 0 417.59797.75 417.59797.75 350.92
Er:YAG 0.9 (7 mm, 0.35 J) 35.9978.09 140.38732.37 117.97
Er:YAG 1.2 (7 mm, 0.45 J) 32.4075.42 126.01721.69 105.89
Er:YAG 1.4 (7 mm, 0.55 J) 43.1574.60 169.04718.41 142.05
Er:YAG 0.9 (7 mm, 0.35 J)  2 24.4976.67 102.39726.66 86.04
Er:YAG 1.8 (5mm, 0.35 J) 32.1075.12 243.50740.16 204.62
Er:YAG 2.8 (5 mm, 0.55 J) 40.6376.11 310.42747.86 260.86
CO2 1.4 (3 mm, surgipulse) 2.7670.27 9.7571.48 8.19
CO2 4.0 (3 mm, surgipulse) 11.6271.06 57.9675.75 48.71
CO2 7.0 (3 mm, powerpulse) 15.2875.27 77.93728.68 65.49
Microdermabrasion 2 s (4 6 mm, 3 bar) 15.5074.16 30.4178.49 25.55
Microdermabrasion 3 s (4 6 mm, 3 bar) 11.3675.39 21.96711.00 18.45
Microdermabrasion 4 s (4 6 mm, 3 bar) 15.6071.99 30.6274.06 25.73
aOriginal £ux was calculated directly from the £ux across partly laser- or microablation-treated skin.
bNormalized £ux was calculated from the £ux across fully laser- or microablation-treated skin (100%) that was calibrated by £ux of control group.
cERwas normalized £ux of laser- or microabrasion-treated group/£ux of control group.
Each value represents mean7SD (n¼ 4).
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far less than that of vitamin C. Exposure of skin to the Er:YAG
laser did not increase the £ux of MAP across the skin at di¡erent
£uences (Table IV). The MAP £ux across 0.9 J per cm2 treated
skin was even signi¢cantly lower (po0.05) than that across
intact skin after determining the statistical analysis. The same
result was observed for the data of MAP uptake by skin, except
that at a £uence of 1.4 J per cm2, there was a slight increase in the
skin deposition of MAP as shown in Table V. It can be inferred
that di¡usion within the vehicle, but not permeation across the
skin, is the rate-determining step for topical delivery of MAP.
Topical delivery of vitamin C by the CO2 laser An intensity
of 1.4 J per cm2 was selected to provide identical £uences for both
the Er:YAG and CO2 lasers compared in this study. It is clear that
a single pulse of 1.4 J per cm2 was su⁄cient for the CO2 laser to
signi¢cantly enhance the transport of vitamin C across skin (Fig
2b). As summarized in Table II, a comparison of the £ux of
vitamin C produced by both lasers suggests that the Er:YAG
laser exerted a greater enhancement e¡ect on drug permeation.
Histologic and structural alterations in the skin may have
produced a great increase in £ux after exposure to the Er:YAG
laser. It is clear that treatment with the CO2 laser at higher
£uences (4.0 and 7.0 J per cm2) signi¢cantly enhanced the skin
transport of vitamin C by 48.71-fold and 65.49-fold, respectively
(Table II). The trend of skin deposition of vitamin C after
various treatments of the CO2 laser was the same as that of the
£ux (Table III).
Topical delivery of vitamin C by microdermabrasion The
histologic results showed that microdermabrasion could e¡ectively
remove the SC layers (Fig 1d), resulting in enhanced vitamin C
permeation across the skin as shown in Fig 2(c). There was no
signi¢cant di¡erence (p40.05) among the £ux of vitamin C
after microdermabrasion treatment of various durations (Table
II). On the other hand, microdermabrasion with 2 s treatment
produced lower enhancement of skin deposition than did the 3 s
and 4 s treatments (po0.05) (Table III).
DISCUSSION
Nude mouse skin was treated by lasers and microdermabrasion to
determine their e¡ects on the integrity of the skin structure.
There were no statistically signi¢cant di¡erences in the SC/epi-
dermis thicknesses determined from treatment using 0.9 and 1.2
J per cm2 (p40.05) for the Er:YAG laser. The Er:YAG laser not
only ablated the SC layers, but also removed a part of the epider-
mal layers at a £uence of 1.4 J per cm2. This may suggest that the
threshold £uence for ablation of viable epidermis is about 1.4 J per
cm2 for the Er:YAG laser. The laser^tissue interactions of the CO2
and Er:YAG lasers signi¢cantly di¡ered. A large fraction of the
incident energy of the CO2 laser is invested in tissue heating
(Seckel et al, 1998; Jacobson et al, 2000). According to previous stu-
dies, the estimated ablation threshold for the CO2 laser is 5 J per
cm2 in human skin (Herd et al, 1999). The energy per pulse must
be above this level for the CO2 laser to have a meaningful e¡ect.
This threshold approximated the result in our study in that a £u-
ence of 4 J per cm2 on nude mouse skin produced a signi¢cant
zone of ablation in the SC and epidermis (Table I).
The mechanism by which microdermabrasion produces
abraded skin is based on high-speed compressed Al2O3 crystals.
The depth of peeling is controlled by the programmed pressure,
not by the touch of the operator (Tsai et al, 1995). This can theore-
tically prevent deep tissue damage and allow precise control of
ablation of the skin. The depth of SC ablation was similar
(p40.05) with treatment of microdermabrasion for 2, 3, and 4 s.
Hence treatment for 2 s may act as a maximum duration to
achieve e¡ective peeling as e¡ects of longer durations may be
restricted to those at the level of 2 s.
According to light-microscopic photographs (Fig 1), lasers and
microdermabrasion produced skin ablation and disruption to dif-
ferent levels. The prerequisite of an ideal permeation-enhancing
method is that the skin should recover its normal barrier proper-
ties following removal of the enhancing method. Previous studies
demonstrated that the depth to which the SC and epidermis
could completely recover within 3 to 5 d was based on di¡erent
£uences used (Lee et al, 2001, 2002). The recovery of skin after
microdermabrasion might not exceed this period, according to
histologic observations and the etched thickness of the SC. These
results indicate that further investigations on developing these
permeation-enhancing methods are warranted.
Vitamin C possessed a very low passive permeability in the
control group. Owing to the lipophilic nature and the ordered
matrix of intercellular lipids of the SC, a hydrophilic molecule
such as vitamin C has di⁄culty partitioning and permeating
into the SC. When stripping the SC by tape, vitamin C could
easily traverse across the viable epidermis/dermis because of the
disappearance of this predominant barrier, which is why the
Table III. The skin depositions and enhancement ratios of vitamin C within nude mouse skin by treatment of lasers and
microdermabrasion
Laser type
Fluence
(J per cm2 or seconds)
Original deposition
(mg per mg102)a
Normalized deposition
(mg per mg102)b
Enhancement ratio
(ERdeposition)
c
Nontreatment 0 3.6871.41 ^ ^
SC stripping 0 471.047157.46 471.047157.46 128.00
Er:YAG 0.9 (7 mm, 0.35 J) 76.30721.43 294.15785.70 79.93
Er:YAG 1.2 (7 mm, 0.45 J) 109.04716.08 424.48764.00 115.35
Er:YAG 1.4 (7 mm, 0.55 J) 71.76735.87 275.987143.47 74.99
Er:YAG 0.9 (7 mm, 0.35 J)  2 68.6076.46 263.34725.85 71.56
Er:YAG 1.8 (5 mm, 0.35 J) 45.7870.78 333.7776.13 90.70
Er:YAG 2.8 (5 mm, 0.55 J) 61.05714.55 453.447114.04 123.22
CO2 1.4 (3 mm, surgipulse) 1.4470.56 ^ ^
CO2 4.0 (3 mm, surgipulse) 10.0372.79 38.24715.19 10.39
CO2 7.0 (3 mm, powerpulse) 49.9377.92 255.50743.11 69.01
Microdermabrasion 2 s (4 6 mm, 3 bar) 23.7575.90 44.65712.04 12.13
Microdermabrasion 3 s (4 6 mm, 3 bar) 45.49710.65 89.48721.27 24.32
Microdermabrasion 4 s (4 6 mm, 3 bar) 45.1172.04 87.9973.45 23.91
aOriginal deposition was calculated directly from the £ux across partly laser- or microablation-treated skin.
bNormalized deposition was calculated from the £ux across fully laser- or microablation-treated skin (100%) which was calibrated by £ux of control group.
cERwas normalized deposition of laser- or microabrasion-treated group/deposition of control group.
Each value represents mean7SD (n¼ 4).
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tape-stripping technique possessed the highest ER£ux value
among all methods examined in this study. Although the skin
deposition of vitamin C was also greatly increased by SC strip-
ping, the ratio of enhancement was lower than the data for £ux.
This may have been due to a lack of the SC drug reservoir within
the skin, resulting in insu⁄cient space for the deposition of vita-
min C. The Er:YAG laser greatly enhanced skin permeation of
vitamin C for all intensities tested. Histologic observations and
ablation levels in the skin may have produced this great increase.
An observation was that the Er:YAG laser at 1.4 J per cm2 not only
removed SC layers, but also ablated a part of viable epidermis
(Table I); however, the vitamin C £ux across Er:YAG laser-trea-
ted skin was greatly lower than that across SC-stripped skin.
Besides the ablation e¡ect on skin, improvement of drug parti-
tioning into the skin may be also important for the enhancement
in vitamin C permeation. Although removal of the epidermis can
reduce the inherent barrier properties of skin, the partitioning of
vitamin C into the viable skin should be decreased. As a result,
increased permeation of the skin due to ablation may be partly
o¡set by a decrease in the partition coe⁄cient between epidermis
and drug vehicle.
Two pulses of irradiation would theoretically produce a greater
disruption of the skin than would one pulse. TEWL indicates the
rate at which water migrates from viable tissues through the layer
of the SC to the external environment. This method demon-
strates a good correlation between skin barrier disruption or
thickness and increase in TEWL (Fang et al, 1997; Alberti et al,
2001). Figure 3 shows TEWL values of skin after treatment with
lasers. Baseline values of nontreated sites were subtracted from
the achieved measurements to give actual changes in TEWL
(W TEWL). The results show that multiple pulses indeed caused
more signi¢cant W TEWL values than that did single pulses
(po0.05). Although removal of a part of the SC and epidermis
can reduce the inherent barrier properties of the skin and thus
increase skin permeation, the partitioning of drugs into the SC
and/or epidermis should be decreased after this removal by two-
pulse treatment.
Discrepancies in skin deposition among various modes of the
Er:YAG laser were not large (Table III). A low correlation coe⁄-
cient (r¼ 0.6088) was calculated between the £uence of the
Er:YAG laser and its ERdeposition value. The o¡set e¡ect by the
reduced skin volume for vitamin C to be deposited at higher £u-
ences may be responsible for this low correlation. On the other
hand, a good relationship (r¼ 0.9588) between Er:YAG £uence
and vitamin C £ux was found (Table II), indicating that the
Er:YAG laser with various modes can precisely control the skin
permeation of vitamin C.There was also an excellent relationship
(r¼ 0.9952) between the £uence andW TEWL value.
MAP, as the prodrug of vitamin C, has been introduced com-
mercially as a skin whitener and radical scavenger (Semenzato
et al, 1995). No measurable amount of MAP was obtained in the
receptor during 12 h, indicating the complete conversion of the
prodrug to vitamin C during the permeation process. Evidence
suggests that MAP is transported into the dermis, where it is con-
verted into vitamin C as a result of dephosphorylation, then it
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Figure 2. Transdermal permeation of vitamin C by Er:YAG laser
(a), CO2 laser (b), and microdermabrasion (c) at various £uences or
treatment durations. Each value represents the mean7SD (n¼ 4).
Table IV. The £uxes and enhancement ratios of MAP across nude mouse skin by treatment of Er:YAG lasera
Laser type
Fluence
(J per cm2 or seconds)
Original £ux
(mg per cm2 per h)b
Enhancement ratio
(ER£ux)
c
Nontreatment 0 1.0270.16 ^
SC stripping 0 12.6471.37 12.39
Er:YAG 0.9 (7 mm, 0.35 J) 0.7670.10 0.75
Er:YAG 1.2 (7 mm, 0.45 J) 0.8670.15 0.84
Er:YAG 1.4 (7 mm, 0.55 J) 1.0270.03 1.00
aThe vitamin C but not MAP was detected in the receptor because of the conversion in skin.
bOriginal £ux was calculated directly from the £ux across partly laser- or microablation-treated skin.
cERwas original £ux of laser- or microablation-treated group/£ux of control group.
Each value represents mean7SD (n¼ 4).
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permeates across the epidermis (Lupo, 2001). The low enhance-
ment of £ux after tape-stripping may indicate that not only the
SC, but also the epidermis/dermis, presents resistance to MAP
permeation. Another possible reason is the a⁄nity of MAP for
the vehicle. Hydrophilic MAP may have been better incorporated
into the test formulation and thus produced a stronger a⁄nity
with this vehicle. This may have contributed to the di⁄culty of
MAP in escaping from the donor vehicle to the skin; that is, the
release of MAP from the formulation was very low. Essentially,
no detectable amount being observed within the intact skin may
indicate the constraint of MAP permeating from the vehicle to
the skin. Neither the £ux nor the skin deposition of MAP appli-
cation increased after exposure of skin to the Er:YAG laser. The
MAP £ux across 0.9 J per cm2 treated skin was even signi¢cantly
lower (po0.05) than that across intact skin. This may be due to
the decrease of the partition coe⁄cient of MAP, which was simi-
lar to the e¡ect of the two-pulse treatment for vitamin C per-
meation. Although a partial removal of SC can reduce the
inherent barrier property of skin, the partitioning of drug into
the SC and the drug reservoir within the skin should be limited
after this removal. In this case of MAP, partitioning may play an
important part governing skin permeation, thus showed no or
negligible e¡ect after treatment with the Er:YAG laser.
With respect to drug permeation across the skin from the aqu-
eous vehicle, a drug should ¢rst di¡use out from the vehicle to
the skin surface. To clarify the mechanism of the skin absorption
of vitamin C and MAP, the release rate of drug from the test for-
mulation across a cellulose membrane (Spectra-Por, molecular
weight cut-o¡ of 12,000^14,000) was studied. The mediums in
the donor and receptor were the same with the experiments of
nude mouse skin. The release rate of vitamin C and MAP after
examination was 353.77718.16 mg per cm2 per h (2.0170.10 mmol
per cm2 per h) and 20.8374.45 mg per cm2 per h (0.0870.02
mmol per cm2 per h), respectively. Hence it is concluded that the
di⁄culty of releasing MAP from the vehicle and partitioning it
across the skin contributed to the low permeation of MAP
following laser treatment.
It was noticed that the CO2 laser at 1.4 J per cm
2 caused no
ablation of either the SC or the epidermis (Table I). The 8.19-fold
increase of vitamin C £ux by the CO2 laser at 1.4 J per cm
2 may
have been due to the slight thermal e¡ect induced at lower £u-
ences. The pulse duration of 50 ms used in this study may be
higher than the thermal relaxation time of the skin (1 ms), result-
ing in thermal injury to the skin without ablation (Herd et al,
1999). Two major observations constituting structural changes in
CO2 laser-treated skin (4.0 and 7.0 J per cm
2) include thermal in-
jury and skin ablation. As observed in Table I, the CO2 laser at
7.0 J per cm2 showed a similar ablation to the Er:YAG laser at 1.4 J
per cm2. The enhancement of vitamin C £ux, however, was
greater for the Er:YAG laser than for the CO2 laser. This may in-
dicate that mechanisms other than the ablation e¡ect dominate
the permeation of vitamin C. The large wavelength of the CO2
laser (10,600 nm) allows deep penetration of skin tissues. The heat
di¡usion by the CO2 laser causes dermal collagen shrinkage,
which is believed to be responsible for tightening of the dermis
(Collawn et al, 1998; Jacobson et al, 2000), resulting in loss of the
extracellular gel matrix surrounding the collagen ¢bers. This
e¡ect may cause a negative result for vitamin C transport across
the skin.
The trend for skin deposition of vitamin C after treatment
with the CO2 laser was the same as that for the £ux. Moreover,
the CO2 laser at 1.4 J per cm
2 showed an inhibitory e¡ect of skin
partitioning (po0.05), which may have been due to dermal
shrinkage. Further studies are needed to elucidate these mechan-
isms. Unlike the Er:YAG laser various £uences of the CO2 laser
produced comparableWTEWL values (Fig 3), although a linear
relationship was determined between the ablated SC thickness
and the £uence. This may suggest that the SC thickness is not a
strict factor predominating the W TEWL value. Structural
changes other than skin ablation are possibly other mechanisms
that can modulateWTEWL.
Microdermabrasion has become an extremely popular form of
super¢cial skin resurfacing. The nonsigni¢cant di¡erence in the
£ux of vitamin C after treatment with microdermabrasion at var-
ious durations was due to the comparable ablation e¡ects of var-
ious treatment durations as shown inTable I. Microdermabrasion
with 2 s treatment caused lower enhancement of skin deposition
TableV. The skin depositions of MAP within nude mouse skin by treatment of Er:YAG lasersa
Laser type
Fluence
(J per cm2 or seconds)
Original deposition
(mg per mg102)b
Normalized deposition
(mg per mg102)c
Nontreatment 0 0 ^
SC stripping 0 20.0872.85 20.0872.85
Er:YAG 0.9 (7 mm, 0.35 J) 0 0
Er:YAG 1.2 (7 mm, 0.45 J) 0 0
Er:YAG 1.4 (7 mm, 0.55 J) 1.2870.28 4.9371.08
aThe vitamin C but not MAP was detected in the skin because of the conversion in skin.
bOriginal deposition was calculated directly from the £ux across partly laser- or microablation-treated skin.
cNormalized deposition was calculated from the £ux across fully laser- or microablation-treated skin (100%) which was calibrated by £ux of control group.
Each value represents mean7SD (n¼ 4).
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Figure 3. TEWL of nude mouse back skin by Er:YAG laser, CO2
laser, and microdermabrasion at various £uences or treatment
durations. Each value represents the mean7SD (n¼ 4).
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than for 3 s and 4 s treatments (Table III). The same trend was
observed forW TEWL by microdermabrasion (Fig 3). A linear
correlation (r¼ 0.9538) was found to exist between skin deposi-
tion of vitamin C andWTEWL exposed by microdermabrasion
at various durations. A good relationship (r¼ 0.9695) was also
observed between treatment duration andW TEWL.
TheWTEWL caused by microdermabrasion was much lower
than those caused by the lasers (Fig 3). It was perceived that the
Er:YAG laser at 0.9 and 1.2 J per cm2 and microdermabrasion
ablated the SC and epidermis to similar thicknesses (p40.05)
(Table I). The results of £ux and skin deposition enhancement
as well as W TEWL, however, showed a great discrepancy be-
tween these two techniques.
This may suggest that factors other than skin ablation contri-
bute to this di¡erence. Histologic observations of skin treated by
microdermabrasion showed that it may simply remove the SC
layers while reserving intact epidermis/dermis (Fig 1d). Previous
studies also demonstrated the same results (Lloyd, 2001; Tan et al,
2001). The Er:YAG laser may also a¡ect skin layers with ultra-
structural alterations not visible in photomicrographs from light
microscopy (Lee et al, 2001). One explanation for this inference
may be the photomechanical acoustic e¡ect generated by the
laser. Local propagation of the acoustic shock wave may cause
‘‘cracking’’of the epidermis (Nelson et al, 1991).The scanning elec-
tric micrograph also showed intervening spaces between the ker-
atinocyte aggregates after irradiation with the Er:YAG laser (Lee
et al, 2002). These e¡ects on the skin could lead to greater drug
permeation across and within the skin by the Er:YAG laser.
In conclusion, all resurfacing techniques tested in this study
show promise for promoting vitamin C topical delivery. Permea-
tion of the prodrug of vitamin C (MAP), however, was not en-
hanced by the Er:YAG laser because of the a⁄nity between the
vehicle and the drug. SC and epidermal removal with these res-
urfacing techniques can be fast and precisely controlled and may
o¡er a distinct advantage over tape-stripping, which is both
macroscopic and unpredictable. The results of this study indicate
that each resurfacing technique had its own characteristics in
modulating skin histology and topical delivery of vitamin C.
Hence lasers and microdermabrasion exhibit their own abilities
to enhance drug transport into and/or across the skin to ¢t di¡er-
ent needs.
1 The Er:YAG laser greatly enhanced vitamin C permeation with
a 86.04-fold to 260.86-fold increase. Skin deposition also showed
71.56-fold to 123.22-fold enhancement. A good correlation was
determined between the laser £uence and vitamin C £ux; how-
ever, there was relationship between £uence and skin deposition
of vitamin C.W TEWL could be a factor re£ecting the magni-
tude of Er:YAG laser £uence because of an excellent correlation
between them.
2 The CO2 laser at a lower £uence (1.4 J per cm
2) induced a 8.19-
fold increase in vitamin C £ux without ablating any of the SC or
epidermal layers. Skin deposition, however, was somewhat lower
at this £uence. The CO2 laser at higher £uences (4.0 and 7.0 J per
cm2) was su⁄cient to ablate the SC and epidermal thickness,
resulting in enhanced vitamin C £ux and skin deposition. The
e¡ect of enhancement was lower than that of the Er:YAG laser,
which may have been due to skin tightening by the CO2 laser.
3 Microdermabrasion moderately increased skin permeation and
deposition of vitamin C by simply ablating a portion of the SC
layers. Both treatment duration and skin deposition showed good
correlations with the value ofW TEWL.
Further studies on the feasibility of in vivo and clinical uses of
these techniques are in progress to explore their practicality.
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